Mirae Asset Global Investments Co., Ltd. Kinnate Biopharma Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$2.24 - $2.66 $25,088 - $29,792	11,200 New	11,200 $29,000
Q1 2023 May 04, 2023	SELL	$3.46 - $7.98 $100 - $231	-29 Reduced 0.24%	12,289 $76,000
Q4 2022 Feb 09, 2023	BUY	$5.26 - $12.19 $84 - $195	16 Added 0.13%	12,318 $75,000
Q3 2022 Nov 10, 2022	BUY	$9.86 - $15.76 $121,297 - $193,879	12,302 New	12,302 $147,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.